SCHEMBL29624927

SCHEMBL29624927

COC(=O)c1nc2cc(C)[nH]c2nc1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
KDM4E B2RXH2 10/20 0.38
ALDH1A1 P00352 8/20 0.38
HPGD P15428 4/20 0.38
ATM Q13315 1/20 0.37
MAPT P10636 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
RXFP1 Q9HBX9 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
HSD17B10 Q99714 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
LMNA P02545 1/20 0.35
VCP P55072 1/20 0.35
ILK Q13418 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21482756 1.00 MAP4K1 (0.41) MAP4K1NPSR1KDM4EALDH1A1HPGD
SCHEMBL21486348 0.86 MAP4K1 (0.42) MAP4K1ALDH1A1MAPTTDP1ADORA2A
SCHEMBL20209580 0.83 MAP4K1 (0.35) MAP4K1ADORA2AADORA1
SCHEMBL20208919 0.79 MAP4K1 (0.36) MAP4K1ADORA2AADORA1VCP
SCHEMBL20187673 0.73 NPSR1 (0.42) NPSR1KDM4EALDH1A1HPGDL3MBTL1
SCHEMBL17090692 0.71 ADORA2A (0.38) MAP4K1NPSR1KDM4EALDH1A1HPGD
SCHEMBL29977899 0.70 NPSR1 (0.56) NPSR1KDM4EALDH1A1HPGDMAPT
SCHEMBL16418573 0.70 NPSR1 (0.56) NPSR1KDM4EALDH1A1HPGDMAPT
SCHEMBL13072745 0.69 ADORA2A (0.37) MAP4K1KDM4EALDH1A1HPGDATM
SCHEMBL27388937 0.69 MAP4K1 (0.48) MAP4K1NPSR1KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110214141-B Benzodiazolium compounds as ENaC inhibitors 企业治疗学有限公司 2022-05-31 CN disclosed